Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H T Tran

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|July 7, 2017
Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinomaA J Zurita, R C Gagnon, Y Liu, et al.
Journal of Medical Case Reports|March 8, 2024
Orbital infarction syndrome following mechanical thrombectomy in internal carotid artery occlusion: a case reportBinh Q Tran, Lanh C Nguyen, Tinh T Trinh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2015
Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assayV A T Nguyen, H Q Nguyen, T T Vu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinomaE Massarelli, H Lin, L E Ginsberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Early development of tendinopathy in humans: Sequence of pathological changes in structure and tissue turnover signalingPeter H T Tran, Nikolaj M Malmgaard-Clausen, Rikke S Puggaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2011
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinomaA J Zurita, E Jonasch, X Wang, et al.
Ophthalmic Genetics|July 23, 1999
Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastomaD H Abramson, C M Frank, G L Chantada, et al.
ESMO Open|November 12, 2025
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
ESMO Open|February 5, 2025
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2023
Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancerH T Tran, S Heeke, S Sujit, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|July 7, 2017
Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinomaA J Zurita, R C Gagnon, Y Liu, et al.
Journal of Medical Case Reports|March 8, 2024
Orbital infarction syndrome following mechanical thrombectomy in internal carotid artery occlusion: a case reportBinh Q Tran, Lanh C Nguyen, Tinh T Trinh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2015
Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assayV A T Nguyen, H Q Nguyen, T T Vu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2015
Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinomaE Massarelli, H Lin, L E Ginsberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Early development of tendinopathy in humans: Sequence of pathological changes in structure and tissue turnover signalingPeter H T Tran, Nikolaj M Malmgaard-Clausen, Rikke S Puggaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2011
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinomaA J Zurita, E Jonasch, X Wang, et al.
Ophthalmic Genetics|July 23, 1999
Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastomaD H Abramson, C M Frank, G L Chantada, et al.
ESMO Open|November 12, 2025
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
ESMO Open|February 5, 2025
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2023
Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancerH T Tran, S Heeke, S Sujit, et al.
Pageof 10